Goldman Sachs - Equity Research - 20 March 2019
We maintain our Buy rating in IPH. Our 12-month target price is A$7.65. We derive ourbase valuation using a 50:50 DCF/PE valuation; we then apply an uplift of 3.6x to theimplied PE valuation to consider IPH’s pursuit of inorganic growth.
Ann: XIP: ACCC review of proposed Xenith IP and QANTM IP merger, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.31 |
Change
-0.045(0.84%) |
Mkt cap ! $1.460B | |||
| Open | High | Low | Value | Volume |
| $5.34 | $5.35 | $5.27 | $2.409M | 454.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 8060 | $5.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.31 | 4869 | 10 |
View Market Depth
| Last trade - 12.53pm 12/11/2024 (20 minute delay) ? |
| IPH (ASX) Chart |